SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16091427
Source:
http://linkedlifedata.com/resource/pubmed/id/16091427
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0008976
,
umls-concept:C0392360
,
umls-concept:C1140680
,
umls-concept:C1516213
,
umls-concept:C1706907
pubmed:issue
11
pubmed:dateCreated
2005-10-20
pubmed:abstractText
Some retrospective analyses have suggested that participation in clinical trials is associated with better outcome. However, it is not clear to what extent selection bias contributes to this observation.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Paclitaxel
,
http://linkedlifedata.com/resource/pubmed/chemical/Topotecan
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0923-7534
pubmed:author
pubmed-author:BurgesAA
,
pubmed-author:GroppMM
,
pubmed-author:HarterPP
,
pubmed-author:HuoberJJ
,
pubmed-author:PfistererJJ
,
pubmed-author:Schade-BrittingerCC
,
pubmed-author:SchmalfeldtBB
,
pubmed-author:StaehleAA
,
pubmed-author:WollschlaegerKK
,
pubmed-author:du BoisAA
pubmed:issnType
Print
pubmed:volume
16
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1801-5
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:16091427-Adult
,
pubmed-meshheading:16091427-Aged
,
pubmed-meshheading:16091427-Aged, 80 and over
,
pubmed-meshheading:16091427-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:16091427-Carboplatin
,
pubmed-meshheading:16091427-Clinical Trials as Topic
,
pubmed-meshheading:16091427-Female
,
pubmed-meshheading:16091427-Humans
,
pubmed-meshheading:16091427-Middle Aged
,
pubmed-meshheading:16091427-Neoplasm Invasiveness
,
pubmed-meshheading:16091427-Neoplasm Staging
,
pubmed-meshheading:16091427-Neoplasms, Glandular and Epithelial
,
pubmed-meshheading:16091427-Neoplasms, Second Primary
,
pubmed-meshheading:16091427-Ovarian Neoplasms
,
pubmed-meshheading:16091427-Paclitaxel
,
pubmed-meshheading:16091427-Patient Participation
,
pubmed-meshheading:16091427-Patient Selection
,
pubmed-meshheading:16091427-Prospective Studies
,
pubmed-meshheading:16091427-Retrospective Studies
,
pubmed-meshheading:16091427-Topotecan
pubmed:year
2005
pubmed:articleTitle
Non-enrolment of ovarian cancer patients in clinical trials: reasons and background.
pubmed:affiliation
HSK, Dr Horst Schmidt Klinik Wiesbaden, Department of Gynaecology & Gynaecological Oncology, Wiesbaden, Germany. p.harter@gmx.de
pubmed:publicationType
Journal Article
,
Multicenter Study